Jurado C, Giménez MP, Menéndez M. Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose. Forensic Sci Int. 2003 Aug 12;135(2):110-4. \[[PubMed: 12927411](https://pubmed.ncbi.nlm.nih.gov/12927411)\] 7. Traub SJ, Hoffman RS, Nelson LS. The "ecstasy" hangover: hyponatremia due to 3,4-methylenedioxymethamphetamine. J Urban Health. 2002 Dec;79(4):549-55. \[[PMC free article: PMC3456731](/pmc/articles/PMC3456731/)\] \[[PubMed: 12468674](https://pubmed.ncbi.nlm.nih.gov/12468674)\] 8. Meyer JS. 3,4-methylenedioxymethamphetamine (MDMA): current perspectives. Subst Abuse Rehabil. 2013;4:83-99. \[[PMC free article: PMC3931692](/pmc/articles/PMC3931692/)\] \[[PubMed: 24648791](https://pubmed.ncbi.nlm.nih.gov/24648791)\] 9. Kiyatkin EA, Ren S. Clubbing with ecstasy. Temperature (Austin). 2014 Oct-Dec;1(3):160-1. \[[PMC free article: PMC5008718](/pmc/articles/PMC5008718/)\] \[[PubMed: 27627800](https://pubmed.ncbi.nlm.nih.gov/27627800)\] 10. Wish ED, Fitzelle DB, O'Grady KE, Hsu MH, Arria AM. Evidence for significant polydrug use among ecstasy-using college students. J Am Coll Health. 2006 Sep-Oct;55(2):99-104. \[[PMC free article: PMC3005618](/pmc/articles/PMC3005618/)\] \[[PubMed: 17017306](https://pubmed.ncbi.nlm.nih.gov/17017306)\] 11. Leshner AI. Ecstasy abuse and control: hearing before the Senate Subcommittee on Governmental Affairs--July 30, 2001. Statement for the record. J Psychoactive Drugs. 2002 Apr-Jun;34(2):133-5. \[[PubMed: 12691202](https://pubmed.ncbi.nlm.nih.gov/12691202)\] 12. Wu LT, Parrott AC, Ringwalt CL, Yang C, Blazer DG. The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions. Am J Addict. 2009 Nov-Dec;18(6):452-61. \[[PMC free article: PMC3075627](/pmc/articles/PMC3075627/)\] \[[PubMed: 19874166](https://pubmed.ncbi.nlm.nih.gov/19874166)\] 13. Passie T, Benzenhöfer U. MDA, MDMA, and other "mescaline-like" substances in the US military's search for a truth drug (1940s to 1960s). Drug Test Anal. 2018 Jan;10(1):72-80. \[[PubMed: 28851034](https://pubmed.ncbi.nlm.nih.gov/28851034)\] 14. Vollenweider FX, Gamma A, Liechti M, Huber T. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers. Neuropsychopharmacology. 1998 Oct;19(4):241-51. \[[PubMed: 9718588](https://pubmed.ncbi.nlm.nih.gov/9718588)\] 15. Parrott AC. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology (Berl). 2004 May;173(3-4):234-41. \[[PubMed: 15007594](https://pubmed.ncbi.nlm.nih.gov/15007594)\] 16. Moritz ML, Kalantar-Zadeh K, Ayus JC. Ecstacy-associated hyponatremia: why are women at risk? Nephrol Dial Transplant. 2013 Sep;28(9):2206-9. \[[PMC free article: PMC3769979](/pmc/articles/PMC3769979/)\] \[[PubMed: 23804804](https://pubmed.ncbi.nlm.nih.gov/23804804)\] 17. Mas M, Farré M, de la Torre R, Roset PN, Ortuño J, Segura J, Camí J. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther. 1999 Jul;290(1):136-45. \[[PubMed: 10381769](https://pubmed.ncbi.nlm.nih.gov/10381769)\] 18. Wu D, Otton SV, Inaba T, Kalow W, Sellers EM. Interactions of amphetamine analogs with human liver CYP2D6. Biochem Pharmacol. 1997 Jun 01;53(11):1605-12. \[[PubMed: 9264312](https://pubmed.ncbi.nlm.nih.gov/9264312)\] 19. De Souza EB, Battaglia G. Effects of MDMA and MDA on brain serotonin neurons: evidence from neurochemical and autoradiographic studies. NIDA Res Monogr. 1989;94:196-222. \[[PubMed: 2575225](https://pubmed.ncbi.nlm.nih.gov/2575225)\] 20. Lai TI, Hwang JJ, Fang CC, Chen WJ. Methylene 3,